Risk Factors for Influenza Virus Related Severe Lower Respiratory Tract Infection in Children

被引:29
作者
Eski, Aykut [1 ]
Ozturk, Gokcen Kartal [1 ]
Gulen, Figen [1 ]
Cicek, Candan [2 ]
Demir, Esen [1 ]
机构
[1] Ege Univ, Childrens Hosp, Fac Med, Dept Pediat Pulmonol, Kazim Karabekir 9, TR-35100 Izmir, Turkey
[2] Ege Univ, Childrens Hosp, Fac Med, Dept Microbiol, Kazim Karabekir 9, Izmir, Turkey
关键词
children; influenza; mortality; severe pulmonary infection; PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; METAANALYSIS; IMPACT; COMPLICATIONS; COLONIZATION; ANTIVIRALS; BURDEN; CARE;
D O I
10.1097/INF.0000000000002447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Influenza virus is one of the most common respiratory pathogens for all age groups and may cause seasonal outbreaks. Our aim was to identify risk groups and factors associated with severe clinical course including mortality in children with influenza-related lower respiratory tract infection (LRTI). Methods: We conducted a retrospective study in children hospitalized with influenza virus LRTI from 2008 to 2018. Data on demographic features, influenza type, viral coinfection, primary and secondary bacterial infections (SBIs), time of onset of antiviral treatment, comorbidities, hospitalization length, pediatric intensive care unit admission/invasive mechanical ventilation (IMV) need and mortality were collected from medical records. Results: There were 280 patients hospitalized with LRTI and median hospitalization length was 9 days. Congenital heart disease, neuromuscular disease, SBIs and late-onset antiviral treatment were independent risk factors for prolonged hospital stay (P < 0.05). Pediatric intensive care unit admission was present in 20.4% (57) of the patients and 17.1% (48) of all patients required IMV. SBIs, lymphopenia, neutrophilia, immunosuppression and human bocavirus coinfection were independent risk factors for IMV support (P < 0.05). Eighteen patients died and immunosuppression, lymphopenia and SBIs were independent risk factors for mortality (P < 0.05). Conclusions: Presence of comorbidity, SBIs, neutrophilia and lymphopenia at admission identified as risk factors for severe influenza infections including need for IMV and death. Although several studies showed that antiviral treatment reduce hospitalization, complications and mortality, there is a lack of prospective trials and patients for antiviral therapy should be carefully chosen by the clinician.
引用
收藏
页码:1090 / 1095
页数:6
相关论文
共 37 条
[1]  
Acar M, 2017, TURK PEDIATR ARSIVI, V52, P15, DOI 10.5152/TurkPediatriArs.2017.4695
[2]   Influenza A(H1N1)pdm09 in critically ill children admitted to a paediatric intensive care unit, South Africa [J].
Ahrens, J. O. ;
Morrow, B. M. ;
Argent, A. C. .
SOUTHERN AFRICAN JOURNAL OF CRITICAL CARE, 2015, 31 (01) :4-7
[3]  
[Anonymous], 2005, POCK BOOK HOSP CAR C
[4]  
Augustyn B, 2007, CRIT CARE NURSE, V27, P32
[5]   Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged &lt;5 Years in the PERCH Study [J].
Baggett, Henry C. ;
Watson, Nora L. ;
Knoll, Maria Deloria ;
Brooks, W. Abdullah ;
Feikin, Daniel R. ;
Hammitt, Laura L. ;
Howie, Stephen R. C. ;
Kotloff, Karen L. ;
Levine, Orin S. ;
Madhi, Shabir A. ;
Murdoch, David R. ;
Scott, J. Anthony G. ;
Thea, Donald M. ;
Antonio, Martin ;
Awori, Juliet O. ;
Baillie, Vicky L. ;
DeLuca, Andrea N. ;
Driscoll, Amanda J. ;
Duncan, Julie ;
Ebruke, Bernard E. ;
Goswami, Doli ;
Higdon, Melissa M. ;
Karron, Ruth A. ;
Moore, David P. ;
Morpeth, Susan C. ;
Mulindwa, Justin M. ;
Park, Daniel E. ;
Paveenkittiporn, Wantana ;
Piralam, Barameht ;
Prosperi, Christine ;
Sow, Samba O. ;
Tapia, Milagritos D. ;
Zaman, Khalequ ;
Zeger, Scott L. ;
O'Brien, Katherine L. .
CLINICAL INFECTIOUS DISEASES, 2017, 64 :S317-S327
[6]   Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies [J].
Belongia, Edward A. ;
Simpson, Melissa D. ;
King, Jennifer P. ;
Sundaram, Maria E. ;
Kelley, Nicholas S. ;
Osterholm, Michael T. ;
McLean, Huong Q. .
LANCET INFECTIOUS DISEASES, 2016, 16 (08) :942-951
[7]   Viral Co-Infections in Pediatric Patients Hospitalized with Lower Tract Acute Respiratory Infections [J].
Cebey-Lopez, Miriam ;
Herberg, Jethro ;
Pardo-Seco, Jacobo ;
Gomez-Carballa, Alberto ;
Martinon-Torres, Nazareth ;
Salas, Antonio ;
Maria Martinon-Sanchez, Jose ;
Gormley, Stuart ;
Sumner, Edward ;
Fink, Colin ;
Martinon-Torres, Federico .
PLOS ONE, 2015, 10 (09)
[8]   The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy [J].
Cromer, Deborah ;
van Hoek, Albert Jan ;
Jit, Mark ;
Edmunds, W. John ;
Fleming, Douglas ;
Miller, Elizabeth .
JOURNAL OF INFECTION, 2014, 68 (04) :363-371
[9]   Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146
[10]   Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials [J].
Falagas, Matthew E. ;
Koletsi, Patra K. ;
Vouloumanou, Evridiki K. ;
Rafailidis, Petros I. ;
Kapaskelis, Anastasios M. ;
Rello, Jordi .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (07) :1330-1346